Conference Information

Welcome Message

Dear researchers and distinguished guests,

It is with great pleasure that I welcome you all to the 5th Annual Congress on Psychiatry and Mental Health. As we gather here, we celebrate the progress we have made in the field of Psychiatry, and look forward to the opportunities and challenges that lie ahead. Psychiatry 2024 will be held in Virtual Mode from June 20-21, 2024.

This congress provides a unique platform for us to come together and share our research, clinical experience, and knowledge with each other. The diverse range of topics and speakers in this congress will enrich our understanding of Psychiatry and help us develop new insights, approaches, and interventions.

We hope this congress will be an opportunity for you to engage in meaningful discussions, network with your peers, and take back valuable insights to your institutions and practices.

Once again, welcome to the 5th Annual Congress on Psychiatry and Mental Health. We look forward to a productive and enriching event.

Best Regards,

Organizing Committee | Psychiatry 2024

Join as group with minimum of 4-5 members and get 20% discount on total registration fee.

Exciting early bird registration perks awaits you. (valid till 2nd phase early bird registration)

Market Analysis

Psychiatry is a branch of medicine that deals with the diagnosis, treatment, and prevention of mental illnesses. The market for psychiatry is an important area of the healthcare industry, as mental illnesses are becoming increasingly prevalent across the globe. In this analysis, we will examine the current state of the psychiatry market, its drivers, and challenges, as well as its growth prospects.

Market Size and Growth

The global psychiatry market is expected to reach a value of USD 150 billion by 2027, growing at a CAGR of 4.1% from 2020 to 2027. The growth is primarily attributed to the increasing prevalence of mental disorders, growing awareness about mental health, and technological advancements in the field.

In terms of geography, North America is the largest market for psychiatry, accounting for approximately 40% of the total market share. The high market share is attributed to the increasing prevalence of mental disorders, favorable reimbursement policies, and availability of advanced healthcare infrastructure. Europe is the second-largest market for psychiatry, followed by Asia-Pacific, Latin America, and the Middle East and Africa.

The psychiatry market is a rapidly growing sector of the healthcare industry. This is due to the increasing demand for mental health services and treatments, as well as the growing awareness and acceptance of mental health issues in society.

One of the key drivers of the psychiatry market is the increasing prevalence of mental health disorders such as depression, anxiety, bipolar disorder, and schizophrenia. This has led to a rise in demand for psychiatric medications and therapies, as well as an increased need for mental health professionals such as psychiatrists, psychologists, and social workers.

The psychiatry market is also being driven by the development of new and innovative treatments for mental health disorders. For example, there are now a variety of pharmaceuticals that are being developed to treat conditions such as depression and anxiety, as well as new therapeutic approaches such as transcranial magnetic stimulation (TMS) and ketamine therapy. Overall, the psychiatry market is expected to continue to grow rapidly in the coming years, as more people seek mental health treatment and as new and more effective treatments are developed.

Drivers and Restraints

The primary drivers of the psychiatry market include the increasing prevalence of mental disorders, growing awareness about mental health, and technological advancements in the field. According to the World Health Organization (WHO), approximately 1 in 4 people globally will experience mental health issues in their lifetime. This has led to an increased demand for psychiatric services and medications, thereby driving the market growth.

Additionally, the growing awareness about mental health and the importance of seeking treatment has resulted in an increase in the number of patients seeking psychiatric care. Governments and healthcare organizations have also taken initiatives to raise awareness and reduce the stigma surrounding mental health issues, further driving the market growth.

On the other hand, the high cost of psychiatric treatments and medications, lack of skilled professionals, and stigma surrounding mental health issues are some of the key restraints to the market growth. The high cost of treatments and medications can discourage patients from seeking care, particularly in low- and middle-income countries. Additionally, the shortage of skilled professionals in the field can also hinder the market growth.

Opportunities and Challenges

The psychiatry market presents several opportunities for growth, particularly in developing countries where the prevalence of mental disorders is high but access to mental healthcare is limited. In such countries, the implementation of government-led initiatives to improve mental healthcare infrastructure can drive the market growth.

Moreover, the growing use of telepsychiatry, which involves the delivery of psychiatric services through telecommunication technologies, presents a significant opportunity for the market growth. Telepsychiatry can help overcome geographical barriers and increase access to mental healthcare services in underserved areas.

However, the market also faces several challenges, including the lack of standardization of treatment protocols, the high cost of psychiatric drugs, and the shortage of trained professionals. Additionally, the COVID-19 pandemic has presented significant challenges to the psychiatry market, with an increase in the number of patients seeking care and the shortage of resources and skilled professionals.

The psychiatry market presents a significant growth opportunity in the healthcare industry, driven by the increasing prevalence of mental disorders, growing awareness about mental health, and technological advancements in the field. However, the market also faces challenges such as the high cost of treatments and medications, shortage of skilled professionals, and lack of standardization of treatment protocols. The implementation of government-led initiatives and the growing use of telepsychiatry present significant opportunities for the market growth, particularly in developing countries where access to mental healthcare is limited.

About Psychiatry 2024

A Psychiatry 2024 conference is an event that brings together mental health professionals, researchers, and advocates to share the latest research, best practices, and innovative ideas in the field of psychiatry. These conferences provide an opportunity for attendees to learn from experts in the field, network with peers, and stay up-to-date with the latest advancements in mental health care.

Psychiatry 2024 conferences typically feature keynote speeches, panel discussions, workshops, and poster presentations on a wide range of topics related to mental health, such as depression, anxiety, addiction, trauma, and schizophrenia. The conferences may also include sessions on new research and treatments, emerging trends in the field, and ethical considerations related to mental health care.

Objectives for the Psychiatry 2024 Conference:

Assimilate cutting-edge study and management strategies into clinical practise in psychiatry.
Identify and classify public psychiatric inconsistencies
Analyze how to incorporate new discoveries into a range of therapies to advance patient care.

Why You Should Attend:

Development of informational and treatment abilities in community psychiatry.
Pay attention to lecturers with nationwide reputations.

Engage with highly informed individuals who "walk the walk" and actively engage with them in discussion to advance your knowledge and practise.
Learn more by engaging in a variety of learning activities, such as moralistic lectures, team meetings, faculty, and engaging case study conversations.
An opportunity for you to interact with your conference attendees, network, and socialise.

Who Should Attend?

We welcome all professionals of primary care, including:

Psychiatrists
Surgeons
Psychotherapists
Nursing professionals
Doctor's assistants
Specialists for marriage and families
Professional psychologists
Health care professionals
The social workers
Graduates, post-graduate students, and Doctorate candidates
Affiliate professors, professors, and assistant professors
Industrial and pharmaceutical companies
Members of research institutes
Business Pioneers

Sessions & Tracks

Track 1: Psychiatry

A medical specialisation called psychiatry is dedicated to the identification, management, and prevention of mental illness and emotional disorders. Doctors of medicine who specialise in diagnosing and treating mental illnesses with a mix of drugs, psychotherapy, and other forms of therapy are known as psychiatrists. Psychiatrists may treat depression, anxiety disorders, bipolar disorder, schizophrenia, and eating disorders among other prevalent mental health issues. Psychiatrists can be found working in a range of places, such as community mental health centres, private offices, hospitals, and clinics.

Psychiatrists are vital contributors to research and instruction in the area of mental health in addition to treating mental health issues. In addition to conducting study on the causes and treatments of mental illness, they also offer other people instruction and training.

Related Journals: Journal of Clinical Psychology and Cognitive Science, Journal of Clinical Psychiatry and Neuroscience, Journal of Psychology & Psychotherapy, Bipolar Disorder: Open Access, Journal of Child and Adolescent Psychiatry and Mental Health, Journal of Experimental Child Psychology, Journal of Educational & Child Psychology, Journal of Child Psychology and Trauma

Related Association & Society: American Psychiatric Association, International Society for Sports Psychiatry, Mississippi Psychiatric Association, San Diego Psychiatry Society, Wisconsin Psychiatric Association, British Psychological Society, Washington State Psychiatry Association, The Japanese Society of Psychiatry Conferences and Neurology Conferences, Indian Association of Biological Psychiatry, World Association of Cultural Psychiatry: WACP

Track 2: Mental health

Mental health refers to the state of an individual's emotional, psychological, and social well-being. It affects how a person thinks, feels, and behaves, and influences their ability to cope with the challenges of daily life. Mental health can be impacted by a range of factors, including genetics, environment, and life experiences. Mental health conditions are common and can range from mild to severe, including conditions such as anxiety disorders, depression, bipolar disorder, schizophrenia, and personality disorders. These conditions can have a significant impact on an individual's quality of life, relationships, and ability to function at work or school.

Treatment for mental health conditions may include a combination of medication, psychotherapy, and lifestyle changes. In some cases, hospitalization may be necessary for individuals experiencing a mental health crisis.

Related Journals: Journal of Clinical Child and Family Psychology, Journal of Child and Adolescent Psychiatry, Journal of Experimental Child Psychology, Journal of Clinical Child and Adolescent Psychology, Journal of Child Psychology, Psychiatry and Mental Health Research, Journal of the American Academy of Child and Adolescent Psychiatry, Journal of Clinical Child Psychology and Psychiatry, International Journal of School and Cognitive Psychology, Journal of Child Psychology & Human Development Mental Health Conferences

Related Association & Society: European Psychiatric Association (EPA), Indian Psychiatric Society, New York County Psychiatry Society of Mental Health, Ohio Psychiatric Physicians Association, International Society for Adolescent Psychiatry Conferences, World Psychiatric Association, Northern California Psychiatric Society, Massachusetts Psychiatric Society, Asia Federation of Psychiatric Associations (AFPA), Australian Psychological Society

Track 3: Psychiatric nursing

The market for psychiatric nursing in psychiatry is growing due to the increasing demand for mental health services and the shortage of mental health professionals. According to a report by Grand View Research, the global psychiatric nursing market size was valued at $139.7 billion in 2020 and is expected to grow at a compound annual growth rate of 4.6% from 2021 to 2028. The market is driven by the increasing prevalence of mental health disorders, growing awareness of mental health issues, and rising investments in mental health services. Key players in the psychiatric nursing market include mental health clinics, hospitals, and private practices, as well as government organizations and non-profit groups.

Track 4: Dementia

The dementia market in psychiatry is witnessing significant growth due to the increasing prevalence of the disease, the aging population, and the growing demand for effective treatment options. According to a report, the global dementia care market size was valued at 40.5 billion USD in 2020 and is expected to grow at a compound annual growth rate of 8.7% from 2021 to 2028. The market is driven by the availability of innovative treatments and therapies, increasing investment in research and development, and rising awareness of the disease. Key players in the dementia market include pharmaceutical companies, healthcare providers, and diagnostic and testing companies.

Related Journals: International Psychiatry Journal, Journal of Psychology, Journal of Australasian Psychiatry, British Journal of Psychiatry, American Journal of Psychiatry, Journal of Psychiatry Research, Journal of World Psychiatry Conferences, Child Mental Health Journal, Journal of Psychiatric and Mental Health Disorders, International Journal of Social Psychiatry and Mental Health Conferences, BMC Psychiatry Journal

Related Association & Society: American Psychological Association (APA), Indian Association for Social Psychiatry, The Psychiatric Association of Turkey (PAT), World Association of Social Psychiatry: WASP, Canadian Psychiatric Association, National Mental Health Organizations, American Association for Geriatric Psychiatry, American Psychiatric Nurses Association, Pennsylvania Psychiatric Society, German Psychological, International Society of Psychiatric-Mental Health Nurses

Track 5: Alzheimer’s Disease

The Alzheimer's disease market in psychiatry is also witnessing significant growth, driven by the aging population and the increasing prevalence of the disease. According to a report by Mordor Intelligence, the global Alzheimer's disease market is expected to grow at a compound annual growth rate of 7.8% from 2021 to 2026, reaching a market size of $8.6 billion by the end of the forecast period. The market is driven by the availability of new drug therapies, increasing investment in research and development, and rising awareness of the disease. Key players in the Alzheimer's disease market include pharmaceutical companies, healthcare providers, and research organizations.

Tracks 6: Schizophrenia

Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. Individuals with schizophrenia often experience a range of symptoms, including delusions, hallucinations, disorganized thinking, and abnormal behaviors. The symptoms can vary in severity and may interfere with an individual's ability to function in daily life. Treatment for schizophrenia typically involves a combination of medication and psychotherapy. Early intervention is important for improving outcomes for individuals with schizophrenia. Prevention efforts include promoting mental health and wellness, reducing exposure to stress and trauma, and providing support and resources to individuals and families affected by the disorder. It is important to note that with proper treatment and support, individuals with schizophrenia can lead fulfilling and productive lives.

Track 7: Autism

The market for autism treatment and management in psychiatry is growing rapidly, driven by increasing prevalence rates and advancements in research and technology. According to a report by Research and Markets, the global autism market is expected to grow at a compound annual growth rate of 5.1% from 2021 to 2028, reaching a market size of 4.6 billion USD by the end of the forecast period. This growth is attributed to the rising awareness of autism and its early detection, as well as the availability of effective interventions and therapies. Key players in the autism market include pharmaceutical companies, behavioral therapy providers, and diagnostic and testing companies.

Track 8: Child and adolescent psychiatry

Child and adolescent psychiatry is a subspecialty of psychiatry that focuses on the diagnosis, treatment, and prevention of mental health disorders in children and adolescents. Child and adolescent psychiatrists work with individuals from infancy through young adulthood, addressing a wide range of emotional, behavioral, and developmental concerns.

Child and adolescent psychiatrists use a variety of treatment approaches, including medication management, psychotherapy, and family therapy. They also collaborate with other healthcare professionals, such as pediatricians, social workers, and psychologists, to provide comprehensive care for their patients. Additionally, they may work with schools and community organizations to address mental health concerns in the broader community.

Track 9: Geriatric psychiatry

Geriatric psychiatry is a specialized field of psychiatry that focuses on the diagnosis, treatment, and prevention of mental health disorders in older adults. As people age, they may experience changes in physical health, cognitive functioning, and social support, which can increase their risk for mental health problems. Some of the common mental health conditions that geriatric psychiatrists may treat include depression, anxiety disorders, dementia, delirium, and substance use disorders. Geriatric psychiatrists use a variety of treatment approaches, including medication management, psychotherapy, and cognitive behavioral therapy. They also work closely with other healthcare professionals, such as primary care physicians, geriatricians, and social workers, to provide comprehensive care for their patients.

Tracks 10: Forensic psychiatry

Forensic psychiatry is a specialized area of psychiatry that involves the interface between mental health and the law. Forensic psychiatrists work with individuals who have mental health disorders and are involved in legal proceedings, such as criminal trials or civil lawsuits. Forensic psychiatrists may be called upon to provide expert testimony in court, to evaluate the mental state of a defendant or witness, or to assess an individual's capacity to make decisions or to stand trial.

Forensic psychiatry requires specialized training and expertise in both mental health and the legal system. Forensic psychiatrists must be knowledgeable about legal concepts such as competency, criminal responsibility, and involuntary commitment, and they must be able to communicate complex mental health issues to legal professionals and lay audiences.

Tracks 11: Addiction psychiatry

Addiction psychiatry is a specialized field of psychiatry that focuses on the diagnosis, treatment, and prevention of substance use disorders and other forms of addiction. Addiction psychiatrists work with individuals who struggle with addiction, as well as their families and communities, to address the complex physical, psychological, and social factors that contribute to addiction.

In addition to treating addiction, addiction psychiatrists may also play a role in preventing addiction and promoting healthy lifestyles. They may work with schools, community organizations, and healthcare providers to promote awareness of the risks associated with substance use, and to provide education and support for individuals and families affected by addiction.

Tracks 12: Alcohol/Substance Abuse

Alcohol and substance abuse are serious mental health conditions that can have a profound impact on an individual's life, relationships, and overall well-being. Substance abuse is characterized by the continued use of drugs or alcohol despite negative consequences, such as physical, psychological, or social harm. The causes of substance abuse can be complex and can involve a combination of genetic, environmental, and psychological factors. Common risk factors include a family history of addiction, trauma, and mental health conditions such as depression and anxiety.

Track 13: Neurodevelopmental Disorders

Neurodevelopmental disorders are a group of conditions that affect the development of the nervous system and brain, resulting in difficulties with learning, communication, and behavior. These disorders are usually present at birth or emerge in early childhood. Some common neurodevelopmental disorders include autism spectrum disorder, attention-deficit/hyperactivity disorder (ADHD), intellectual disability, and specific learning disorders. These disorders can have a significant impact on an individual's academic, social, and emotional functioning.

The causes of neurodevelopmental disorders are complex and can involve a combination of genetic, environmental, and biological factors. Early diagnosis and intervention are important in helping individuals with neurodevelopmental disorders reach their full potential.

Track 14: Depression and anxiety

Depression and anxiety are two common mental health conditions that fall under the field of psychiatry. Depression is a mood disorder characterized by persistent feelings of sadness, hopelessness, and loss of interest in activities that were once enjoyed. Symptoms may also include changes in appetite, sleep disturbances, fatigue, and difficulty concentrating.

Anxiety, on the other hand, is a group of disorders characterized by excessive and persistent worry or fear about everyday situations. Symptoms may include physical symptoms such as sweating, trembling, or rapid heartbeat, as well as psychological symptoms such as feeling restless, tense, or on edge. Both depression and anxiety can be treated with various approaches in psychiatry, including medication, psychotherapy, or a combination of both. Common medications used to treat these conditions include antidepressants, anxiolytics, and mood stabilizers.

Track 15: Stress disorders

Stress disorders are a group of mental health conditions that fall under the field of psychiatry. These disorders are characterized by a significant emotional or psychological response to a traumatic or stressful event. Post-traumatic stress disorder (PTSD) is one of the most well-known stress disorders. It occurs when someone has experienced or witnessed a traumatic event such as a natural disaster, combat, or physical assault. Symptoms of PTSD can include intrusive memories or flashbacks of the event, avoidance of people or places that may trigger memories of the trauma, and increased arousal such as hyper-vigilance or difficulty sleeping. Acute stress disorder (ASD) is another stress disorder that occurs in response to a traumatic event. ASD symptoms are similar to PTSD but are typically more short-lived, lasting between three days and one month after the event.

Tracks 16: Personality disorders

Personality disorders are a group of mental health conditions characterized by inflexible and maladaptive patterns of thinking, feeling, and behaving that deviate significantly from cultural and societal norms. These patterns are typically established in adolescence or early adulthood and can cause significant distress and impairment in social, occupational, and other areas of functioning.

There are several types of personality disorders, including borderline personality disorder, narcissistic personality disorder, antisocial personality disorder, and obsessive-compulsive personality disorder, among others. Each type of personality disorder is associated with specific traits and behaviors that can affect an individual's relationships, self-esteem, and sense of identity.

Tracks 17: Paraphilic disorders

Paraphilic disorders are a group of mental health conditions characterized by intense and persistent sexual urges, fantasies, or behaviors that involve atypical objects, activities, or individuals. These urges, fantasies, or behaviors can cause significant distress or impairment in social, occupational, or other areas of functioning.

Treatment for paraphilic disorders may involve psychotherapy, medication, or a combination of both. Cognitive-behavioral therapy (CBT) and other forms of psychotherapy can help individuals with paraphilic disorders learn coping strategies, develop healthy sexual behaviors, and address underlying psychological issues. Medications, such as antidepressants and anti-androgens, may be used to reduce sexual urges and prevent recidivism.

Tracks 18: Bipolar and Related Disorder

Manic-depressive illness, or bipolar disorder, is a brain disorder that results in unusual changes in mood, energy, activity levels, and the capacity to perform daily activities. Bipolar and related disorders are a group of mental health conditions characterized by fluctuations in mood, energy, and activity levels. These disorders include bipolar I disorder, bipolar II disorder, cyclothymic disorder, and other specified and unspecified bipolar and related disorders. The signs of mania and hypomania, which are two different kinds of episodes, are the same and include increased activity, unusual talkativeness, a reduced need for sleep, distractibility, and poor decision-making. Atypical antipsychotics, mood stabilisers, and antidepressants are some of the drugs used in treatment.

Tracks 19: Eating disorders

Eating disorders are a group of mental health conditions characterized by abnormal eating habits and attitudes towards food and body weight that cause significant distress or impairment in social, occupational, or other areas of functioning. The three main types of eating disorders are anorexia nervosa, bulimia nervosa, and binge-eating disorder. Anorexia nervosa is characterized by severe restriction of food intake, an intense fear of gaining weight or becoming fat, and a distorted body image. People with anorexia nervosa may also engage in excessive exercise, and they may become dangerously thin. Bulimia nervosa is characterized by recurrent episodes of binge eating followed by compensatory behaviors such as vomiting, laxative use, or excessive exercise. People with bulimia nervosa often maintain a normal body weight, but their binge eating and compensatory behaviors can cause significant distress or impairment.

Track 20: Sleep Disorders

Sleep disorders are a group of conditions that affect the quality and quantity of sleep. These disorders include insomnia, sleep apnea, restless legs syndrome, and narcolepsy, among others. Insomnia involves difficulty falling asleep, staying asleep, or waking up too early. Sleep apnea involves interruptions in breathing during sleep, which can lead to daytime sleepiness and fatigue. Restless legs syndrome involves uncomfortable sensations in the legs that are relieved by movement. Narcolepsy involves excessive daytime sleepiness and sudden episodes of sleep. The exact cause of sleep disorders is not known, but genetic, environmental, and lifestyle factors are thought to play a role. Risk factors for sleep disorders include obesity, age, stress, and certain medical conditions such as depression and anxiety.

Track 21: Psychiatric Diagnosis

Psychiatric diagnosis is the process of identifying and categorizing mental health disorders based on a set of diagnostic criteria. The primary purpose of psychiatric diagnosis is to guide treatment decisions and improve outcomes for individuals with mental health conditions. Psychiatric diagnosis is typically based on a comprehensive evaluation of an individual's symptoms, medical and psychiatric history, and current functioning. Diagnostic criteria are outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM), which is published by the American Psychiatric Association.

The DSM includes diagnostic criteria for a range of mental health conditions, including mood disorders, anxiety disorders, personality disorders, substance use disorders, and psychotic disorders, among others. The diagnostic criteria are based on observable symptoms and behaviors, as well as subjective experiences such as thoughts and feelings.

Track 22: Psychiatric rehabilitation

Psychiatric rehabilitation is a process that aims to help individuals with mental health conditions achieve their personal goals and lead fulfilling lives. It involves a range of interventions and services designed to support individuals in their recovery from mental illness and promote their independence, social integration, and quality of life. Psychiatric rehabilitation is based on the principles of recovery, which emphasize the importance of hope, self-determination, and empowerment in the process of mental health recovery. The approach is holistic and person-centered, taking into account the individual's unique needs, preferences, and strengths. Psychiatric rehabilitation services may include psychotherapy, medication management, vocational and educational support, housing assistance, social skills training, and peer support.

Track 23: Pain Management

Pain management is the branch of medicine that focuses on the prevention, evaluation, diagnosis, and treatment of pain. Pain can be acute, such as from an injury or surgery, or chronic, such as from a medical condition or injury that persists for longer than three months. Pain management strategies can include medications, physical therapy, psychological therapy, nerve blocks, and other interventions designed to reduce pain and improve overall functioning. The goals of pain management are to improve quality of life, reduce suffering, and promote overall wellness.

Track 24: Psychiatric Treatment

Psychiatric treatment refers to the range of interventions and services designed to help individuals with mental health conditions improve their symptoms and overall functioning. The goal of psychiatric treatment is to promote mental health and well-being, reduce suffering, and improve quality of life. Psychiatric treatment can involve a range of approaches, including psychotherapy, medication management, behavioral interventions, and social support. The specific treatment approach will depend on the individual's unique needs, preferences, and goals. Psychotherapy is a common form of psychiatric treatment that involves working with a trained mental health professional to address psychological and emotional challenges. This may include individual therapy, group therapy, or family therapy. Different types of psychotherapy include cognitive-behavioral therapy, psychodynamic therapy, and interpersonal therapy, among others.

Track 25: Psychopharmacology

Psychopharmacology is the branch of medicine that focuses on the study of the effects of medications on mental health conditions. It involves the use of medications to treat psychiatric disorders, such as depression, anxiety, bipolar disorder, and schizophrenia, among others. Psychopharmacology works by targeting specific neurotransmitters in the brain, such as dopamine, serotonin, and norepinephrine, among others. These neurotransmitters are chemicals that transmit signals between nerve cells in the brain, and imbalances in these chemicals can contribute to the development of mental health conditions.

Track 26: Clinical trials

Clinical trials in psychiatry involve research studies designed to investigate the safety and effectiveness of new treatments, interventions, and medications for mental health conditions. Clinical trials are typically conducted in three phases, each with a different focus and goal. Clinical trials in psychiatry can involve a range of interventions, including medications, psychotherapy, and other behavioral interventions. These studies are critical for advancing the field of psychiatry and improving the lives of individuals with mental health conditions. Participating in a clinical trial can provide individuals with access to cutting-edge treatments and expert care, while also contributing to the advancement of scientific knowledge. However, it is important to carefully consider the risks and benefits of participating in a clinical trial and to work closely with healthcare providers to make an informed decision.

5^th Annual Congress on
Psychiatry & Mental Health

1st Phase Registration ends on

Quick Links

Theme: Transforming Mental Health: Innovations and Best Practices in Psychiatry

Conference Information

Welcome Message

Market Analysis

About Psychiatry 2024

Sessions & Tracks